tradingkey.logo

Pyxis Oncology Inc <PYXS.OQ> expected to post a loss of 29 cents a share - Earnings Preview

ReutersMay 9, 2025 3:13 PM
  • Pyxis Oncology Inc PYXS.OQ PYXS.O is expected to show a fall in quarterly revenue when it reports results on May 12 (estimated) for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Pyxis Oncology Inc is for a loss of 29 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Pyxis Oncology Inc is $6.00​, above​ its last closing price of $1.09. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.34

-0.33

-0.25

Beat

24.2

Sep. 30 2024

-0.31

-0.31

-0.35

Missed

-11.7

Jun. 30 2024

-0.32

-0.32

-0.29

Beat

10.6​

Mar. 31 2024

-0.21

-0.24

-0.06

Beat

75.2

​​Dec. 31 2023

-0.48

-0.47

-0.33

Beat

30.5

Sep. 30 2023

-0.49

-0.51

-0.56

Missed

-10.5​

Jun. 30 2023

-0.64

-0.65

-0.41

Beat

36.7

Mar. 31 2023

-0.90

-0.90

-0.55

Beat

38.8

This summary was machine generated May 9 at 15:13 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI